- Home
- ACIC vs EVMN Comparison
ACIC vs EVMN Comparison
Compare ACIC & EVMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
HOLD
Current Price
$12.45
Company Overview
Basic Information| Metric | ACIC | EVMN |
|---|---|---|
| Founded | 1999 | 2020 |
| Country | United States | United States |
| Employees | N/A | 48 |
| Industry | Property-Casualty Insurers | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 540.4M | 475.8M |
| IPO Year | 2007 | N/A |
Fundamental Metrics
Financial Performance| Metric | ACIC | EVMN |
|---|---|---|
| Price | $10.15 | $12.45 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 1 | 10 |
| Target Price | N/A | ★ $43.88 |
| AVG Volume (30 Days) | 297.9K | ★ 1.4M |
| Earning Date | 05-05-2026 | 06-11-2026 |
| Dividend Yield | ★ 6.33% | N/A |
| EPS Growth | ★ 39.61 | N/A |
| EPS | ★ 0.39 | N/A |
| Revenue | ★ $335,439,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $1.00 | N/A |
| P/E Ratio | $27.72 | ★ N/A |
| Revenue Growth | ★ 13.07 | N/A |
| 52 Week Low | $9.80 | $11.94 |
| 52 Week High | $13.06 | $33.20 |
Technical Indicators
Market Signals| Indicator | ACIC | EVMN |
|---|---|---|
| Relative Strength Index (RSI) | 34.52 | 32.23 |
| Support Level | $9.80 | N/A |
| Resistance Level | $11.52 | $22.14 |
| Average True Range (ATR) | 0.35 | 1.44 |
| MACD | -0.08 | -0.33 |
| Stochastic Oscillator | 1.89 | 6.28 |
Price Performance
Historical Comparison ACIC
EVMN
About ACIC American Coastal Insurance Corporation
American Coastal Insurance Corp is a holding company that underwrites commercial residential property and casualty insurance policies in the United States through its wholly-owned insurance subsidiary.
About EVMN Evommune Inc.
Evommune Inc is a clinical-stage biotechnology company focused on creating new therapies aimed at key factors driving chronic inflammatory diseases. The initial clinical programs of the company target chronic spontaneous urticaria (CSU), atopic dermatitis (AD), and ulcerative colitis (UC). The pipeline products of the company include EVO756 and EVO301.